BD Diagnostics, Baltimore, has received FDA clearance for its BD ProbeTec Trichomonas vaginalis QxAmplified DNA Assay for the direct qualitative detection of T. vaginalis DNA in endocervical and vaginal samples, as well as neat urine specimens to aid in the diagnosis of trichomoniasis.
The assay is designed for use with the BD Viper System (pictured). Automated DNA extraction and simultaneous amplification and detection maximize lab efficiency and quality of results.
The system allows labs to test samples in panel mode for T. vaginalis, C. trachomatis, and N. gonorrhea or in batch mode for chlamydia and gonorrhea, trichomonas, and herpes on the same automated platform.
Compared to wet mount microscopy and culture, this assay reduces human intervention and associated variables and improves speed to results.